Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic Strategies—A Systematic Review
Background/Objectives: Molecular classification has reshaped risk assessment in endometrial cancer (EC), but the strength and clinical applicability of the evidence vary across molecular subgroups, assay platforms, patient populations, and treatment settings. This systematic review critically evaluated the prognostic a...